85. 特発性間質性肺炎 Idiopathic interstitial pneumonia Clinical trials / Disease details

臨床試験数 : 598 / 薬物数 : 435 - (DrugBank : 116) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 210

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-jRCTs061180046	17/01/2013	12/03/2019	CBDCA, PTX and BV for NSCLC (non-sq) with IP	Phase II study of carboplatin, weekly paclitaxel and bevacizumab for advanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumonia - IP002	Non-squamous, non-small cell lung cancer Lung cancer	Carboplatin (AUC=5) given on day1, paclitaxel (70mg/m2) given on days 1,8,15 and bevacizumab (15mg/m2) on day 1 every 4weeks until disease progression or unmanageable toxicity.	Katakami Nobuyuki	NULL	Complete	>= 20age old	Not applicable	Both	35	Phase 2	Japan
2	JPRN-UMIN000018322	2012/12/01	15/07/2015	Phase II study of carboplatin, weekly paclitaxel and bevacizumab for advanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumonia		advanced non-squamous cell, non-small-cell lung cancer with idiopathic interstitial pneumonia	carboplatin AUC = 5, day1 paclitaxel 70mg/m2, day1 ,8 ,15 bevacizumab 15mg/kg, day1 every 4 weeks, 4-6 cycle	IP lung cancer study group	NULL	Recruiting	20years-old	Not applicable	Male and Female	35	Phase 2	Japan